Bicycle Therapeutics (BCYC) Restructuring Costs (2024 - 2026)

Bicycle Therapeutics (BCYC) has 3 years of Restructuring Costs data on file, last reported at $2.0 million in Q2 2026.

• Quarterly Restructuring Costs fell 15.21% year-over-year to $2.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.6 million (down 0.71% YoY) and the FY2025 annual result came in at $9.6 million, up 5.86% from the prior year.
• Restructuring Costs declined to $2.0 million in Q2 2026, from $2.5 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $2.6 million in Q4 2024 to a low of $1.9 million in Q2 2024.
• A 3-year average of $2.3 million and a median of $2.4 million in 2025 frame the typical range for Restructuring Costs.
• Annual changes were most pronounced in 2025 — Restructuring Costs climbed 21.45% — and 2026, when it retreated 15.21%.
• Tracing BCYC's Restructuring Costs over 3 years: stood at $2.6 million in 2024, then changed by 0.0% to $2.6 million in 2025, then fell by 23.65% to $2.0 million in 2026.
• The last three Restructuring Costs figures came in at $2.0 million (Q2 2026), $2.5 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.